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Abstract
The need for novel antibiotics in an era where antimicrobial resistance is on the rise, and the number of new approved
antimicrobial drugs reaching the market is declining, is evident. The underused potential of post-translationally modified
peptides for clinical use makes this class of peptides interesting candidates. In this study, we made use of the vast amounts
of available genomic data and screened all publicly available prokaryotic genomes (~3000) to identify 394 novel head-to-tail
cyclized antimicrobial peptides. To verify these in silico results, we isolated and characterized a novel antimicrobial peptide
from Bacillus pumilus that we named pumilarin. Pumilarin was demonstrated to have a circular structure and showed
antimicrobial activity against several indicator strains, including pathogens.
DATA SUMMARY
Four supplementary tables and five supplementary figures
are available in four supplementary files, three of which can
be found online in Figshare at https://figshare.com/s/
d318500f36414b4ccfe5 and the other one can be found in
the online Supplementary Material. All supporting data,
code and protocols have been provided within the article or
through supplementary data files or public repositories.
INTRODUCTION
The vast class of post-translationally modified peptides dem-
onstrates a wide variety of chemical structures present in
them [1]. These peptides are highly interesting not only due
to their diverse biological activities but also due to their differ-
ent chemical structures that often result in improved activity
and stability. An interesting group of ribosomally synthesized
and post-translationally modified peptides is the one encom-
passing bacterial head-to-tail cyclized peptides, commonly
referred to as circular bacteriocins [2–4]. These circular bac-
teriocins arise after the cleavage of a leader peptide and the
formation of a peptide bond between the N- and C-termini.
Little is known yet about the circularization mechanism of
circular bacteriocins compared to other smaller circular pep-
tides coming from ribosomal synthesis, such as cyclotides,
cyanobactins or pilins [5]. Nevertheless, the presence of a cir-
cular backbone clearly shows an increased stability and anti-
microbial activity compared to linear counterparts [6–8]. A
renewed interest in bacteriocins and post-translationally
modified peptides has emerged due to their potential in thera-
peutics [9–12] and the utility that some of the enzymes can
have in the stabilization of biologically active peptides [13,
14]. Although diverse chemical and enzymatic processes have
been studied for the production of circular proteins, this is
still challenging, and natural discovery and production
remains the main source of novel circular peptides [15, 16].
Circular bacteriocins characterized so far display a saposin-
fold, which is similar to the structure of leaderless bacterio-
cins [4, 17, 18]. Two main subclasses are suggested based on
structural and biochemical characteristics. Subclass I encom-
passes larger strongly cationic peptides with four or five heli-
ces, whereas subclass II includes acidic circular bacteriocins
[19]. The antimicrobial activity of circular bacteriocins is
based on pore formation, although the mechanisms involved
are different [4]. Carnocyclin A is a monomeric peptide that
creates pores in a voltage-dependent manner [20, 21],
whereas AS-48 is present in solution as a dimeric bacteriocin
that does not require voltage to create toroidal pores [22, 23].
Recently, a maltose transporter has been suggested to increase
the sensitivity to garvicin ML [24].
Received 13 May 2017; Accepted 1 September 2017
Author affiliations: 1Molecular Genetics, University of Groningen, Groningen, Nijenborgh 7, NA 9747 AG, The Netherlands; 2Department of
Microbiology, University of Granada, Granada, Spain.
*Correspondence: Oscar P. Kuipers, o.p.kuipers@rug.nl
Keywords: genome-mining; bacteriocin; circular peptide; antimicrobial peptide; annotation.
Abbreviations: CID, collision-induced dissociation; TFA, trifluoroacetic acid.
†These authors contributed equally to this work.
Data statement: All supporting data, code and protocols have been provided within the article or through supplementary data files. Four
supplementary tables and five supplementary figures are available with the online Supplementary Material.
RESEARCH ARTICLE
van Heel et al., Microbial Genomics 2017;3
DOI 10.1099/mgen.0.000134
000134 ã 2017 The Authors
This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/, which permits unrestricted use, distribution and reproduction in any medium, provided the original
author and source are credited.
1
Downloaded from www.microbiologyresearch.org by
IP:  150.214.23.191
On: Wed, 07 Nov 2018 07:37:06
The prototype of circular bacteriocins is the enterocin AS-
48, produced by Enterococcus faecalis subsp. liquefaciens S-
48 [25, 26]. AS-48 has a broad antimicrobial spectrum
targeting mostly Gram-positive bacteria such as Listeria,
Bacillus, Enterococcus and Staphylococcus, but also some
Gram-negative micro-organisms such as Escherichia coli or
Salmonella [25]. The genes encoding proteins that are
responsible for the production of and resistance to AS-48
are located on the conjugative plasmid pMB2 (see Fig. 1b)
[27]. AS-48 and natural variants of AS-48 have been found
in other enterococcal species receiving diverse names: bacte-
riocin 21 [28], enterocin 4 [29], EFS2 [30], UGRA10 [31],
RM6 [32] and AS-48RJ [33], which is so far the only variant
that is not plasmid based. The presence of AS-48 in entero-
coccal strains of such a diverse origin points at a wide distri-
bution of AS-48 variants in nature.
The production of AS-48 requires the coordinated expres-
sion of 10 genes arranged in three operons, although some
ambiguities exist in the literature regarding the length of the
ORFs and the promoters regulating the production [4, 27,
28, 34, 35]. In addition to the structural gene as-48A, there
are two transporters, as-48C1D and as-48EFGH, involved in
production and immunity, respectively, an immunity pro-
tein, as-48D1, and two additional ORFs, as-48B and as-48C
[2, 26]. Notably, homologues of As-48C containing a so
called SpoIIM (PF01944, previously known as DUF95)
motif are found in other head-to-tail cyclized bacteriocin
clusters [19], this domain is related to both immunity and
circularization [36].
In recent years, diverse bioinformatics tools have been devel-
oped to mine genomic sequences for clusters encoding ribo-
somal and non-ribosomal natural products [37, 38], and even
to link genotype to phenotype using high-resolution techni-
ques such as MS in a high-throughput manner [39]. These
tools, in combination with cheap and fast DNA sequencing,
can help focus research efforts on strains that actually encode
the capability of producing new antimicrobial compounds
[40]. Genome mining has proved to be efficient for the identi-
fication of novel molecules, such as the lantibiotics lichenici-
din [41] and prochlorosins [42]. Here we report the results
from in silico mining for novel head-to-tail cyclized peptides
using BAGEL3 on all publicly available genomes (hosted on the
National Center for Biotechnology Information site; http://
ftp.ncbi.nlm.nih.gov). A total of 394 potential clusters were
identified that encoded 59 unique peptides. To validate our
results, we focused our experimental efforts on a new cluster
found in Bacillus pumilus B4107 [43]. This resulted in the
identification, production, purification and characterization
of a novel head-to-tail cyclized antimicrobial peptide we
named pumilarin, which is, to the best of our knowledge, the
first of its kind in B. pumilus.
METHODS
Genome mining for head-to-tail cyclized peptides
BAGEL3 [38] was run on all public prokaryotic genomes
found on the National Center for Biotechnology
Information ftp server (https://ftp.ncbi.nlm.nih.gov/
genomes/refseq/bacteria/) (October 2013). This involved
roughly 3000 genomes. The results were filtered to only
contain clusters identified based on the SpoIIM (PF01944)
domain (previously known as DUF95). The PF01944
domain was chosen because it is the least common but con-
served domain that is present in the biosynthesis gene clus-
ters of head-to-tail circularized bacteriocins. Next, only
clusters in which a potential prepeptide could be identified
were selected. The results were organized according to
homology to known head-to-tail cyclized peptides.
Strains and media
The strains used in this study are listed in Table S1 (avail-
able in the online Supplementary Material). Bacillus strains,
B. pumilus B4107, Micrococcus flavus and Listeria monocy-
togenes were grown in LB (Oxoid) at 30

C with vigorous
shaking (200 r.p.m.). The other bacteria listed were grown at
37

C in M17 medium (Oxoid) supplemented with 0.5%
glucose (GM17). B. pumilus B4107 was grown on complex
medium for bacteriocin production and isolation [44].
Bacteriocin purification
The purification of pumilarin was performed using cationic
exchange and reversed-phase chromatography. The proto-
col was slightly modified from that of Abriouel et al. [45].
Briefly, a 2 l flask containing 0.5 l complex medium was
inoculated 1 : 20 with an overnight culture of B. pumilus
B4107 and was grown for 8 h (30

C, shaking at 200 r.p.m.)
after which rehydrated CM Sephadex C-25 resin (GE
Healthcare) was added to the culture in a 1 : 40 ratio (v/v).
The mixture was incubated for 1 h with shaking to allow
binding of the cationic compounds to the resin and subse-
quently left standing for 1 h (so that the resin settled). The
top of the mixture was decanted into a waste container and
the rest (containing the resin) was packed into a glass col-
umn. The column was washed with three volumes of wash-
ing buffer (20mM phosphate buffer pH 6.5). Next,
pumilarin was eluted from the column with five volumes of
elution buffer (1.5 M NaCl, 20mM phosphate buffer pH
IMPACT STATEMENT
Genome mining approaches are powerful in identifying
novel natural products, reducing the search space for
novel molecules and focusing screening efforts. In this
study, we focused specifically on the intriguing group of
head-to-tail cyclized antimicrobial peptides. These circu-
lar bacteriocins are post-translationally modified so that
their N- and C-termini are fused. This cyclized structure
can make proteins more resistant to degradation. The in
silico mining efforts not only resulted in many newly
identified peptides, but also yielded a new active antimi-
crobial we named pumilarin. Characterization of this
compound also confirmed the predicted circular
structure.
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6.5). Pumilarin was further purified and desalted using
reversed-phase chromatography in an open C18 (Spherical
C18 Supelco) column. The resin was equilibrated in 0.1%
trifluoroacetic acid (TFA) prior to the application of the
samples. The elution was performed with three elution steps
using three volumes of 33, 66 and 100% organic solvent
(isopropanol : acetonitrile 2: 1 0.1% TFA). All the steps were
monitored using activity tests. Pumilarin was purified to
homogeneity by HPLC in an Agilent 1260 series chroma-
tographer using an Aeris peptide 3.6 u XB-C18
2504.6mm column and 0.1% TFA dissolved in isopropa-
nol : acetonitrile 2 : 1 as the mobile phase. The peptide was
injected to the column equilibrated in 5% organic solvent.
The concentration of organic solvent increased in 5min to
60% and the peptide eluted in a gradient going up to 70%
organic solvent in 15min.
MS and fingerprinting
Matrix-assisted laser desorption/ionization-time of flight
(MALDI-TOF) MS analysis was performed as described
elsewhere [46] using a Voyager DE Pro mass spectrometer.
Determination of mass and circularity was performed as
described elsewhere [32]. Briefly, 5 µl of a HPLC fraction
containing the intact peptide was directly infused using
Fig. 1. (a) Alignment of peptides identified with BAGEL3 that show similarity to enterocin AS-48 (top, leader peptides; bottom, core pepti-
des). Pumilarin was identified in silico in B. pumilus B4107, B. pumilus BA06 BA_1113 (NZ_AMDH01000012.1, WP_017358050.1), B.
pumilus S-1 scaffold28 (NZ_JH137674.1, WP_017358050.1), Bacillus sp. M 2–6 strain KACC 16563 241_9 (leader T2A)
(NZ_AJWW01000009.1, WP_008342549.1). An asterisk (*) indicates a single, fully conserved residue. A colon (:) indicates conservation
within groups of residues with strongly similar properties. A period (.) indicates conservation within groups of residues with weakly
similar properties. (b) Gene clusters responsible for the production of (putative) head-to-tail cyclized peptides. Image created using
Genome2d (http://genome2d.molgenrug.nl). Genes are named according to the AS-48 nomenclature, other names that are indicated
are the PFAM names of the PFAM domains with the best hits.
van Heel et al., Microbial Genomics 2017;3
3
Downloaded from www.microbiologyresearch.org by
IP:  150.214.23.191
On: Wed, 07 Nov 2018 07:37:06
static nanospray with a 2 µm tip (Picotip; New Objective).
Survey scans were recorded using a Thermo Scientific LTQ
Orbitrap XL at a FT resolution of 60 000 at m/z 400 using a
1.3 kV spray voltage for 2min. The major charged signal of
the 7 KDa peptide at m/z 1418 (5+) was selected for colli-
sion-induced dissociation (CID) at 35% in the iontrap and
analysed in the Orbitrap at a resolution of 6000 for 5min.
Internal fragment masses were calculated using MS-product
from Prospector (http://prospector.ucsf.edu/prospector/cgi-
bin/msform.cgi?form=msproduct). Fragments were consid-
ered as detected when the mass matched the theoretical
mass by at least two decimal precision.
Proteolysis assays
HPLC purified and lyophilized pumilarin was resuspended
in 50mM Tris, 5mM CaCl2, pH 7.8 and incubated at 37

C
for 4 h in the presence of sequencing grade trypsin, protein-
ase K or a-chymotrypsin. Proteolysis using pepsin was per-
formed in 0.04M HCl at 37

C for 4 h and the reaction with
protease XIV or endoprotease Glu-C was conducted in
50mM ammonium bicarbonate pH 8.0 at 37

C for 4 h. All
the enzymes were provided by Sigma-Aldrich. They were
dissolved in the reaction buffer at 1mgml 1 and added at a
ratio enzyme:substrate 1 : 50. BSA (1mgml 1) was used as a
control. The cleavage was monitored by analytical HPLC as
described elsewhere [8].
Activity tests
In order to test the production of pumilarin in solid media,
5 µl overnight culture of B. pumilus B4107 was spotted on
minimal expression medium [47], GM17, LB, brain heart
infusion broth or complex medium [44]. It was incubated
overnight at 30

C. The culture was overlaid with 6ml
GM17 0.75% agar buffered with 0.1 M phosphate buffer
(pH 7.0) and inoculated with 200 µl overnight culture. The
overlay was grown until the inhibition halos were visible.
The spot-on-lawn technique was used to monitor the purifi-
cation steps and to compare the inhibition of pumilarin and
the enterocin AS-48, used as a reference. In this case, the
appropriate solid medium was melted and inoculated at 1%
(v/v) with an overnight culture of the sensitive strain. The
plates contained an equal volume (13ml) of melted agar
with inoculum. A total of 5 µl of a purified bacteriocin dis-
solved in 20mM phosphate buffer pH 6.5 was spotted on
top of the agar. The plate was incubated until the inhibition
halos were visible. The experiment was conducted in dupli-
cate. The concentration of the samples was determined by
measuring the absorbance in the UV range using the molar
extinction coefficient calculated with http://web.expasy.org/
protparam/.
To determine the MIC for pumilarin growth assays were
performed using a 96 well plate reader (Tecan infinite
F200). To every well, 135 µl appropriate medium with 1%
(v/v) inoculum and 15 µl two-fold bacteriocin dilution,
quantified as indicated above, was added (total volume
150 µl). The OD600 was monitored for 16 h under appropri-
ate growth conditions. The indicator strain was grown
overnight, diluted 1 : 50 in the morning and grown until it
reached mid-exponential growth prior to addition.
Secondary structure prediction
The secondary structure prediction of the head-to-tail
cyclized bacteriocins was performed on the PSIPRED server
[48, 49].
RESULTS
Identification of 394 gene clusters encoding head-
to-tail cyclized bacteriocins
In an effort to gain insight into the prevalence of head-to-
tail cyclized antimicrobial peptides and to find new ones, we
screened all publicly available genomes using BAGEL3. We
identified 394 genetic clusters potentially encoding a head-
to-tail cyclized peptide [see Table S2 (https://figshare.com/
s/d318500f36414b4ccfe5)]. These 394 clusters encoded 59
unique sequences that had at least one amino acid difference
in the leader or core peptide. All 394 clusters contained at
least a potential prepeptide and a protein encoding a
PF01944 domain, which is also found in the As-48C pre-
dicted protein and other sequenced head-to-tail cyclized
bacteriocin gene clusters [36, 50]. A total of 43 of the 394
gene clusters contained a prepeptide with homology to a
known circular bacteriocin. One cluster identified in diverse
strains of Staphylococcus aureus was conserved (100%
identity at the amino acid level of the prepeptides) in 230 of
the 473 sequenced strains at the time of the BAGEL3 run.
Another conserved cluster was found in 53 of the 275
sequences of Streptococcus pneumoniae. Additionally, we
found four other clusters in the genus Streptococcus. In
Oenococcus oeni, we found at least one cluster in 12 out of
the 15 sequenced strains. Of these 12 strains, 8 contained
two or more head-to-tail cyclized bacteriocin clusters. In the
genus Lactobacillus, we identified five clusters mostly (four
out of five) showing weak homology to known clusters. In
the genus Geobacillus, we identified five clusters all showing
weak homology to the circularin A cluster. In diverse Bacil-
lus species, we found 53 clusters, of which 27 were unique
and 15 of which the prepeptides showed (weak) homology
to known circular bacteriocins. Furthermore, we identified
12 clusters in other bacteria. We generated alignments
(using ClustalW), aligning the newly identified circular pep-
tides to known circular peptides. This resulted in alignments
for four subclasses: enterocin AS-48-like (see Fig. 1), butyri-
vibriocin-like (see Fig. S1), circularin A-like (see Fig. S2)
and uberolysin-like (see Fig. S3). A figure of the taxon distri-
bution can be found in the supplementary information (see
Fig. S4) All full protein sequences and accession numbers
can be found in Table S2.
The AS-48-like class alignment (Fig. 1a, top) of putative
leaders only shows strong homologies at their C-terminal
part. At the  8 to  4 position, a L**LP motif is clearly visi-
ble. In spite of the low sequence homology, the secondary
structure prediction shows a large helix in the leader peptide
that is disrupted by the L**LP motif in all cases and a small
van Heel et al., Microbial Genomics 2017;3
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helix formed by the end of the leader peptide and the first
residues in the core peptide (Fig. S4). The core peptides
(Fig. 1a, bottom) contain several strongly conserved regions.
At the start of the core peptides a (L/M)(A/V)KEF(G/N)(I/
L) motif can be observed. At position 20, a negatively
charged amino acid is present in all cases (E/D). Further-
more, all residues involved in helix 4 (residues 36–47; see
Fig. 1a) are very conserved in all the variants. Another con-
served region covers the end of helix 4 and the beginning of
helix 5 (residues 60 to 70; see Fig. 1a). Thus, it is important
to note that both the N- and the C-termini that are linked
during biosynthesis are conserved.
The gene clusters all have a different composition when
compared to the gene cluster of AS-48. Although all clusters
do have the main part (homologues to As-48ABCC1D),
responsible for production (as-48A, as-48B and as-48C) and
transport (as-48C1D), in common, the immunity associated
genes are sometimes lacking or present in an opposite direc-
tion (as-48D1 and as-48EFGH). Notably, the as-48E gene
was not identified in any of the other clusters. Another
interesting observation is the fact that no specific immunity
related genes were identified in the pumilarin cluster. The
typical small cationic hydrophobic protein (D1 in AS-48)
could not be identified in the gene clusters of pumilarin and
Bacillus sp. GeD10. In the cluster identified in Micrococcus
luteus, no homologues of the immunity-associated trans-
porter As-48EFGH were identified, but this might be due to
the fact that the DNA contig ends after the As-48D1 homo-
logue. Nevertheless, in an in silico study on streptococcal
species, a prevalent putative gene cluster encoding circular
bacteriocins was found that does not contain an immunity-
related transporter either.
B. pumilus B4107 produces a novel circular
bacteriocin: pumilarin
To validate our in silico screening results, we focused our
attention towards the AS-48-like clusters we identified. We
choose this group because of strain availability and because
we had experience working with AS-48. We attempted to
purify and characterize the circular bacteriocin identified in
B. pumilus B4107, which we called pumilarin. First, we
attempted the production in different solid media, monitor-
ing it by activity tests against Micrococcus flavus, Listeria
monocytogenes and Enterococcus faecalis JH2-2. In all cases,
after the incubation we could detect an inhibition zone
around B. pumilus B4107 colonies (data not shown). These
results were indicative that B. pumilus B4107 was producing
an inhibitory agent. In order to determine whether that
agent is the predicted head-to-tail cyclized peptide, we puri-
fied cationic hydrophobic proteins from 1 l supernatant of a
B. pumilus culture according to predicted physico-chemical
properties. The approximate yield of the overall purification
process rendered roughly 100–200 µg HPLC-grade pumi-
larin (l supernatant) 1 HPLC-grade pumilarin. Large varia-
tion in the yield was observed in the different batches
purified. The HPLC purified peptide that retained activity
was analysed by a Thermo Fisher Orbitrap (Fig. 2a) showing
a mono isotopic peak of ~1417.6233Da, which corresponds
to a five times [m/z difference between the different isotope
peaks is 0.2 (1/0.2=5)] ionized peptide. The observed mono-
isotopic mass of this peptide is, therefore, 7083.0768Da [=
(51417.6233)–5.0397], this 0.0074Da less than the
expected mono-isotopic mass of the whole peptide
7083.0694 [=7101.08 18.010565Da (cyclization)]. The loss
of approximately 18Da that was observed is consistent with
a dehydration derived from the peptide bond formation
between the N-terminal Leu and the C-terminal Trp. To
unambiguously prove this assumed circularity, we per-
formed CID to fragment the peptide. Among the observed
fragments there were masses (1129.64, 1016.56Da) perfectly
corresponding to peptide fragments containing both the C-
terminal Leu and the N-terminal Trp (AVIAWLAKEF/
IAWLAKEFGI, IAWLAKEFG/AWLAKEFGI) (see Fig. 2b).
In addition, trypsin and other proteases were tested to prove
the peptidic nature of the inhibitory compound and its
resistance against proteolysis (Fig. S5). Pumilarin showed
high resistance to proteolysis, similarly to previous reports
on AS-48. After 4 h digestion the non-specific proteases a-
chymotrypsin, pepsin, protease XIV and proteinase K were
able to significantly degrade the protein, whereas the more
specific proteases endoprotease Glu-C and trypsin did not
have a pronounced effect.
Pumilarin has a broad antimicrobial spectrum
including Gram-negative targets
Purified pumilarin was tested against a panel of Gram-posi-
tive and Gram-negative bacteria including foodborne patho-
gens and clinically relevant multidrug resistant strains, such
as Staphylococcus aureus and Enterococcus faecalis. The
activity of pumilarin was compared in the test with that of
the reference head-to-tail cyclized bacteriocin AS-48, and
the data are summarized in Tables 1 and 2. In a more quali-
tative spot-on-lawn antimicrobial assays (see Table 1), pum-
ilarin displayed an activity weaker than that of AS-48
against all the strains used, except against E. coli where
pumilarin produced a clearance. Both bacteriocins were par-
ticularly active against the Bacillus strains analysed. The
activity of pumilarin against meticillin-resistant Staphylo-
coccus aureus (strains CAL and MW2) and Enterococcus
faecalis was also reduced. Notably, the producer strain B.
pumilus B4107 was sensitive to both AS-48 and pumilarin
using relative high amounts of peptide.
In antimicrobial activity assays performed in liquid
(Table 2), pumilarin showed strong activity against Micro-
coccus flavus B423 (MIC 2.9 µgml 1), and intermediate
activity against Bacillus cereus ATTC14579, B. pumilus
B4107 and E. coli DH5a (MIC 11.75 µgml 1). Weak activity
was observed against Streptococcus pneumoniae D39 (MIC
47 µgml 1). Pumilarin outperformed AS-48 in three cases
(B. cereus ATCC14579, E. coli DH5a and Micrococcus fla-
vus). In one case, the determined MIC was identical (B.
pumilus B4107). AS-48 showed a much lower MIC against
Streptococcus pneumoniae.
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DISCUSSION
The fact that almost 400 head-to-tail cyclized bacteriocin
clusters were identified in the approximately 3000 screened
strains highlights their widespread occurrence. However,
only 11 different head-to-tail cyclized bacteriocins have
been isolated from nature to date [3, 51]. The large number
of identified clusters might be biased due to large number of
Staphylococcus aureus and Streptococcus pneumoniae
sequences that have been screened and the frequent occur-
rence of circular peptides in these strains. Roughly half of
the unique prepeptides were identified in the genus Bacillus,
indicating a high diversity of head-to-tail cyclized bacterio-
cins in this genus. Almost all clusters were identified in
genomes within the phylum Firmicutes, except for five clus-
ters found in propionibacteria and notably one cluster
found in the Gram-negative lignin-degrading Novosphin-
gobium sp. B-7. The identification of the gene cluster of
pumilarin and other head-to-tail cyclized peptides by
genome mining provides also valuable information regard-
ing conserved residues in the peptide sequence that might
play a role in the recognition by the yet unidentified matu-
ration enzymes and in peptide circularization. The role of
the different residues involved in the leader peptide cleavage
and circularization was studied in enterocin AS-48 [52].
Most circular bacteriocins, including pumilarin (Fig. 1),
carry an aromatic residue in the C-terminal position (either
Trp or Tyr) and, therefore, it has been hypothesized that
they play an important role during cyclization [5, 26, 52]. In
fact, the mutant W70A of the enterocin AS-48 displayed
impaired cyclization activity that allowed the purification of
a linear form of AS-48. The first amino acid in the propep-
tide is also well conserved, being in most cases a Leu, except
for AS-48, which has a Met. The leader peptide of diverse
ribosomally and post-translationally modified peptides
(RiPPs) has been shown to be a recognition/activation
sequence for the modification machinery, a secretion signal
and a way to keep the prepeptide inactive during the pro-
duction [53, 54]. However, there is no clear homology
between the leader peptides of the different circular bacter-
iocins, which range between 35 to 3 amino acids [26]. The
leader peptides show more sequence variability. Only a con-
served L**LP motif in the C-terminal part of the leader is
conserved in the circular bacteriocins with an extended
leader peptide such as AS-48 and pumilarin. The presence
of a conserved proline at the  4 position could disrupt the
helical conformation predicted for the leader peptide of AS-
48 and facilitate the access to the leader peptidase/cyclase
enzyme(s) (see top alignment of Fig. 1a). The diversity of
amino acids at the  1 position and the lack of expression of
the mutant AS-48 H-1I could indicate a preference in this
position for polar or even negatively charged amino acids
over hydrophobic residues except in the circularin A
homologues.
The identification of new gene clusters encoding for circular
bacteriocins shows that often the homologues of As-48D1
EFGH (immunity determinants) are not found in the gene
clusters. The opposite orientation of the as-48FGH homo-
logues and the fact that as-48D1EFGH homologues have
their own promoter in addition to the promoter P2
upstream as-48C1 [55] suggests that this transporter could
have been acquired later during evolution. The knock-out
mutants of As-48EFGH were able to produce AS-48,
although they showed increased sensitivity [35]. It has been
reported that in garvicin ML mutants lacking the homolo-
gous genes showed no increased sensitivity and no clear
function could be assigned to them in the production of gar-
vicin ML [50]. In the latter case, the presence of an As-48D1
homologue and the immunity conferred by the PF01944
containing protein [36] resulted in wild-type level immu-
nity. Our data show that B. pumilus B4107 is sensitive to
AS-48 and pumilarin. This could potentially be due to the
lack of As-48D1EFGH homologues. The sensitivity of the
pumilarin-producing strain is similar to that of the other B.
pumilus strain tested and the other Bacillus species in gen-
eral. This is clearly in contrast to Enterococcus faecalis JH2-2
(pAM401-81), which is resistant to high concentrations of
purified AS-48 [35]. These data suggest that the expression
of additional immunity determinants in B. pumilus B4107
could be a feasible strategy to increase the production level
Fig. 2. (a) The exact mass determination of pumilarin shown here is
the (most prevalent) five times charged (since the difference between
the isotope peaks in m/z is 0.2) variant. The theoretical mass of the
protein is 7083.0694 (7105 18 the mass that is lost during cycliza-
tion), which is in line with the observed mass 7083.0768
[1417.62335 (five times charged)=7088.9 (51.00794)=7083.0768].
(b) Observed fragments connecting the N- and C-termini. The active
purified protein pumilarin was further analysed by MS/MS. After the
first MS step, pumilarin was selected and subsequently fragmented by
CID and the mass of the resulting fragments was recorded in the sec-
ond MS step. Depicted here are the observed fragments that contain
the N- and C-termini of the antimicrobial protein in line with the circu-
lar nature of the compound (for full spectra see Tables S3 and S4;
https://figshare.com/s/d318500f36414b4ccfe5).
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of pumilarin in the same way as it has been achieved with
subtilin [56].
The primary structure and charge distribution in pumilarin
is very similar to that of AS-48; therefore, a common mech-
anism of action is expected. AS-48 DF-I structure is formed
by two protomers with a strong dipolar moment that
approximate the membrane of the target cell due to charge
interactions. This dimer is then disassembled and
transforms into the membrane inserted DF-II form to create
toroidal pores [22, 23, 57]. The presence of four Glu resi-
dues in AS-48 in a plane dividing the charged domain and
the hydrophobic core [18] is a feature conserved in pumi-
larin. Other AS-48-like head-to-tail cyclized peptides keep
at least three out of the four negatively charged amino acids,
although the one in position 49 (numbered according to
AS-48 sequence) is mutated into Gln in some cases. Single
replacements of Glu into Ala showed that, in spite of being
highly conserved, the negative charge reduction is tolerated
although a 2- to 10-fold increase in the MIC was observed
[58]. More important is the effect of the mutation Trp24Ala,
which caused a dramatic increase in the MIC of AS-48.
Pumilarin has an Ala in position 24. We can observe that in
this case the MIC compared to AS-48 is not so different,
probably due to the additional changes present in pumi-
larin, which might compensate for the lack of Trp24.
Pumilarin has a relatively broad antimicrobial spectrum,
but particularly strong against bacilli. The MIC data pre-
sented in this work suggest that pumilarin is evolved in such
a way that the specific activity against other bacilli is poten-
tiated. The activity is particularly high against B. cereus and
Bacillus subtilis in the plate assays performed. However, the
Table 1. Comparison of the antimicrobial activity of pumilarin and AS-48 by spot-on-lawn technique
The concentration of the samples was determined by measuring the absorbance under UV. E. faecalis, Enterococcus faecalis; L. lactis, Lactococcus lac-
tis; M. flavus, Micrococcus flavus; M. smegmatis, Mycobacterium smegmatis; S. aureus, Staphylococcus aureus.
Sensitive strain Bacteriocin 230 µgml 1 57.5 µgml 1 14.4 µgml 1 3.6 µgml 1
B. cereus ATCC14579 AS-48 + +    
Pumilarin + +    
B. pumilus B4107 AS-48 + +    
Pumilarin + +/     
B. pumilus KMM62 AS-48 + +    
Pumilarin + +    
B. subtilis 168 AS-48 + +    
Pumilarin + +/     
E. faecalis JH202 AS-48 + +    
Pumilarin        
E. faecalis V538 AS-48 + +    
Pumilarin        
E. faecalis VE14089 AS-48 + +    
Pumilarin        
E. coli DH5a AS-48        
Pumilarin +/       
L. lactis NZ9000 AS-48 + +    
Pumilarin +      
M. flavus B423 AS-48 +      
Pumilarin +      
M. smegmatis AS-48        
Pumilarin        
S. aureus CAL AS-48 +/       
Pumilarin        
S. aureus MW2 AS-48        
Pumilarin +/       
Table 2. Comparison of the MIC of pumilarin and AS-48 determined by
broth microdilution assay
The concentration of the samples was determined by measuring the






B. cereus ATCC14579 12 >12
B. pumilus B4107 12 12
E. coli DH5a 12 >47
M. flavus B423 3 >12
S. pneumoniae D39 47 3
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activity against lactic acid bacteria, Staphylococcus aureus or
Listeria monocytogenes is relatively reduced. Surprisingly, B.
pumilus B4107 shows sensitivity to both AS-48 and purified
pumilarin, which indicates that the self-immunity machin-
ery is not as efficient as that of AS-48. The fact that Entero-
coccus faecalis S-48 is fully resistant to AS-48, whereas B.
pumilus B4107 is sensitive to both bacteriocins, seems to
indicate that there is not full cross resistance between circu-
lar bacteriocins in spite of their high similarity. This fact
was already observed testing lactocyclicin Q and leucocycli-
cin Q against the respective producer strains [59]. Interest-
ingly, pumilarin displays some activity against E. coli that is
not observed for other head-to-tail antimicrobial peptides,
indicating that pumilarin could be a good starting point for
peptide engineering to obtain highly relevant activity against
Gram-negative pathogens.
The study presented here highlights the strength of genome
mining approaches for the discovery of novel natural prod-
ucts with high potential. Using this approach, we have iden-
tified and compared a large set of gene clusters potentially
encoding novel head-to-tail cyclized bacteriocins. As an
example, we have isolated and characterized pumilarin, a
novel head-to-tail cyclized bacteriocin with a broad antimi-
crobial spectrum and promising biotechnological properties
in food preservation and medicine.
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